Targeting the interface of the pathological complex of α-synuclein and TPPP/p25

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 12, 2015, Pages 2653-2661

  Szunyogh, Sándor ^a   Oláh, Judit ^a   Szénási, Tibor ^a   Szabó, Adél ^a   Ovádi, Judit ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Binding motives; Neomorphic moonlighting function; Parkinson's disease; TPPP p25; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; INTRINSICALLY DISORDERED PROTEIN; PROTEIN P25; TUBULIN POLYMERIZATION PROMOTING PROTEIN; UNCLASSIFIED DRUG; ZINC;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CHO CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; WILD TYPE;

EID: 84942627137     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.09.012     Document Type: Article

References (46)

1. Irvine G.B., El-Agnaf O.M., Shankar G.M., Walsh D.M. Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol. Med. 2008, 14:451-464.
2. Kovacs G.G., László L., Kovács J., Jensen P.H., Lindersson E., Botond G., Molnár T., Perczel A., Hudecz F., Mezo G., Erdei A., Tirián L., Lehotzky A., Gelpi E., Budka H., Ovádi J. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol. Dis. 2004, 17:155-162.
3. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6469-6473.
4. Fink A.L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 2005, 15:35-41.
5. Dunker A.K., Silman I., Uversky V.N., Sussman J.L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 2008, 18:756-764.
6. Uversky V.N. What does it mean to be natively unfolded?. Eur. J. Biochem. 2002, 269:2-12.
7. Jeffery C.J. Moonlighting proteins. Trends Biochem. Sci. 1999, 24:8-11.
8. Jeffery C.J. Proteins with neomorphic moonlighting functions in disease. IUBMB Life 2011, 63:489-494.
9. Tokési N., Oláh J., Hlavanda E., Szunyogh S., Szabó A., Babos F., Magyar A., Lehotzky A., Vass E., Ovádi J. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25. Biochim. Biophys. Acta 2014, 1842:547-557.
10. Hlavanda E., Kovács J., Oláh J., Orosz F., Medzihradszky K.F., Ovádi J. Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations. Biochemistry 2002, 41:8657-8664.
11. Lehotzky A., Tirián L., Tokési N., Lénárt P., Szabó B., Kovács J., Ovádi J. Dynamic targeting of microtubules by TPPP/p25 affects cell survival. J. Cell Sci. 2004, 117:6249-6259.
12. Tokési N., Lehotzky A., Horváth I., Szabó B., Oláh J., Lau P., Ovádi J. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6. J. Biol. Chem. 2010, 285:17896-17906.
13. Takahashi M., Tomizawa K., Fujita S.C., Sato K., Uchida T., Imahori K. A brain-specific protein p25 is localized and associated with oligodendrocytes, neuropil, and fiber-like structures of the CA hippocampal region in the rat brain. J. Neurochem. 1993, 60:228-235.
14. Lehotzky A., Lau P., Tokési N., Muja N., Hudson L.D., Ovádi J. Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation. Glia 2010, 58:157-168.
15. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10:524-530.
16. Preusser M., Lehotzky A., Budka H., Ovádi J., Kovacs G.G. TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells. Acta Neuropathol. 2007, 113:213-215.
17. Zotter A., Bodor A., Oláh J., Hlavanda E., Orosz F., Perczel A., Ovádi J. Disordered TPPP/p25 binds GTP and displays Mg(2+)-dependent GTPase activity. FEBS Lett. 2011, 585:803-808.
18. 2+-induced rearrangement of the disordered TPPP/p25 affects its microtubule assembly and GTPase activity. Biochemistry 2011, 50:9568-9578.
19. Oláh J., Tokési N., Lehotzky A., Orosz F., Ovádi J. Moonlighting microtubule-associated proteins: regulatory functions by day and pathological functions at night. Cytoskeleton (Hoboken) 2013, 70:677-685.
20. Bellucci A., Navarria L., Zaltieri M., Missale C., Spano P. Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease. Brain Res. 2012, 1432:95-113.
21. 2+ with the protein alpha-synuclein and the abeta peptide: a comparative analysis. J. Inorg. Biochem. 2012, 117:334-341.
22. Lindersson E., Lundvig D., Petersen C., Madsen P., Nyengaard J.R., Hojrup P., Moos T., Otzen D., Gai W.P., Blumbergs P.C., Jensen P.H. p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J. Biol. Chem. 2005, 280:5703-5715.
23. Maroteaux L., Campanelli J.T., Scheller R.H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 1988, 8:2804-2815.
24. Bates C.A., Zheng W. Brain disposition of alpha-synuclein: roles of brain barrier systems and implications for Parkinson's disease. Fluids Barriers CNS 2014, 11:17.
25. Danzer K.M., Kranich L.R., Ruf W.P., Cagsal-Getkin O., Winslow A.R., Zhu L., Vanderburg C.R., McLean P.J. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 2012, 7:42.
26. Lee S.J., Desplats P., Lee H.J., Spencer B., Masliah E. Cell-to-cell transmission of alpha-synuclein aggregates. Methods Mol. Biol. 2012, 849:347-359.
27. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
28. Vincze O., Oláh J., Zádori D., Klivényi P., Vécsei L., Ovádi J. A new myelin protein, TPPP/p25, reduced in demyelinated lesions is enriched in cerebrospinal fluid of multiple sclerosis. Biochem. Biophys. Res. Commun. 2011, 409:137-141.
29. Oláh J., Vincze O., Virok D., Simon D., Bozso Z., Tokési N., Horváth I., Hlavanda E., Kovács J., Magyar A., Szucs M., Orosz F., Penke B., Ovádi J. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J. Biol. Chem. 2011, 286:34088-34100.
30. Paleologou K.E., Schmid A.W., Rospigliosi C.C., Kim H.Y., Lamberto G.R., Fredenburg R.A., Lansbury P.T., Fernandez C.O., Eliezer D., Zweckstetter M., Lashuel H.A. Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. J. Biol. Chem. 2008, 283:16895-16905.
31. Tabor S., Richardson C.C. A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:1074-1078.
32. Vincze O., Tokési N., Oláh J., Hlavanda E., Zotter Á., Horváth I., Lehotzky A., Tirián L., Medzihradszky K.F., Kovács J., Orosz F., Ovádi J. Tubulin polymerization promoting proteins (TPPPs): members of a new family with distinct structures and functions. Biochemistry 2006, 45:13818-13826.
33. Paik S.R., Lee J.H., Kim D.H., Chang C.S., Kim J. Aluminum-induced structural alterations of the precursor of the non-a beta component of Alzheimer's disease amyloid. Arch. Biochem. Biophys. 1997, 344:325-334.
34. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100kDa. Anal. Biochem. 1987, 166:368-379.
35. Baaske P., Wienken C.J., Reineck P., Duhr S., Braun D. Optical thermophoresis for quantifying the buffer dependence of aptamer binding. Angew. Chem. Int. Ed. Engl. 2010, 49:2238-2241.
36. Jerabek-Willemsen M., Wienken C.J., Braun D., Baaske P., Duhr S. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 2011, 9:342-353.
37. Seidel S.A., Dijkman P.M., Lea W.A., van den Bogaart G., Jerabek-Willemsen M., Lazic A., Joseph J.S., Srinivasan P., Baaske P., Simeonov A., Katritch I., Melo F.A., Ladbury J.E., Schreiber G., Watts A., Braun D., Duhr S. Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods 2013, 59:301-315.
38. Oláh J., Tokési N., Vincze O., Horváth I., Lehotzky A., Erdei A., Szájli E., Medzihradszky K.F., Orosz F., Kovács G.G., Ovádi J. Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies. FEBS Lett. 2006, 580:5807-5814.
39. Tirián L., Hlavanda E., Oláh J., Horváth I., Orosz F., Szabó B., Kovács J., Szabad J., Ovádi J. TPPP/p25 promotes tubulin assemblies and blocks mitotic spindle formation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13976-13981.
40. Semisotnov G.V., Rodionova N.A., Razgulyaev O.I., Uversky V.N., Gripas A.F., Gilmanshin R.I. Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 1991, 31:119-128.
41. Leal S.S., Gomes C.M. Studies of the molten globule state of ferredoxin: structural characterization and implications on protein folding and iron-sulfur center assembly. Proteins 2007, 68:606-616.
42. Wenning G.K., Stefanova N., Jellinger K.A., Poewe W., Schlossmacher M.G. Multiple system atrophy: a primary oligodendrogliopathy. Ann. Neurol. 2008, 64:239-246.
43. Hasegawa T., Baba T., Kobayashi M., Konno M., Sugeno N., Kikuchi A., Itoyama Y., Takeda A. Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. Neurochem. Int. 2010, 57:857-866.
44. Lee H.J., Suk J.E., Bae E.J., Lee J.H., Paik S.R., Lee S.J. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 2008, 40:1835-1849.
45. Kisos H., Pukass K., Ben-Hur T., Richter-Landsberg C., Sharon R. Increased neuronal alpha-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling alpha-synucleinopathies. PLoS One 2012, 7.
46. Borghi R., Marchese R., Negro A., Marinelli L., Forloni G., Zaccheo D., Abbruzzese G., Tabaton M. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 2000, 287:65-67.